Mirati Therapeutics, Inc. (37)

Browse by Contract Category

Contracts

Separation Agreement and Release, dated December 15, 2021, by and between the Registrant and Dan Faga (Filed With SEC on February 28, 2022)
Amended and Restated Second Amendment to Letter Agreement, effective September 20, 2021, by and between the Registrant and Dr. James Christensen (Filed With SEC on February 28, 2022)
Underwriting Agreement, dated November 10, 2021 (Filed With SEC on November 12, 2021)
Collaboration and License Agreement, dated May 28, 2021, by and among the Company and Zai Lab (Hong Kong) Limited (Filed With SEC on August 5, 2021)
Seventh Amendment to Lease to 9393 Towne Centre, dated November 30, 2020 (Filed With SEC on February 25, 2021)
Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 28, 2022)
Employment Agreement, dated September 17, 2021, by and between the Registrant and David (Filed With SEC on November 8, 2021)
Third Amendment to Amended and Restated Employment Agreement, dated September 20, 2021, by and between the Registrant and Dr. Charles M. Baum (Filed With SEC on November 8, 2021)
Second Amendment to Letter (Filed With SEC on May 6, 2021)
Second Amendment to Letter Agreement, effective December 31, 2020, by and between the Registrant and Dr. James Christensen (Filed With SEC on May 6, 2021)
Letter Agreement, dated December 18, 2019, by and between the Registrant and Benjamin Hickey (Filed With SEC on February 25, 2021)
Letter Agreement, dated December 20, 2019, by and between the Registrant and Dan Faga (Filed With SEC on February 25, 2021)
Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2021)
Description of Capital Stock (Filed With SEC on February 25, 2021)
Sixth Amendment to Lease to 9393 Towne Centre Drive, dated July 15, 2020 (Filed With SEC on November 4, 2020)
Fifth Amendment to Lease to 9393 Towne Centre Drive, dated March 4, 2020 (Filed With SEC on November 4, 2020)
Underwriting Agreement, dated October 27, 2020 (Filed With SEC on October 28, 2020)
Separation and Release Agreement, dated June 1, 2020, by and between the Registrant and Isan Chen (Filed With SEC on August 6, 2020)
Sales Agreement, dated July 2, 2020, between Mirati Therapeutics, Inc. and Cowen and Company, LLC (Filed With SEC on July 2, 2020)
Separation and Release Agreement, dated January 3, 2020, by and between the Registrant and Chris LeMasters (Filed With SEC on May 7, 2020)
Separation and Release Agreement, dated January 3, 2020, by and between the Registrant and Jamie Donadio (Filed With SEC on May 7, 2020)
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under the Amended and Restated 2013 Equity Incentive Plan (Filed With SEC on February 26, 2020)
Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 26, 2020)
Description of Capital Stock (Filed With SEC on February 26, 2020)
Underwriting Agreement, dated January 9, 2020 (Filed With SEC on January 10, 2020)
Form of Stock Option Grant Notice and Stock Option Agreement under Mirati Therapeutics, Inc. Inducement Plan (Filed With SEC on December 31, 2019)
Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under Mirati Therapeutics, Inc. Inducement Plan (Filed With SEC on December 31, 2019)
Mirati Therapeutics, Inc. Inducement Plan (Filed With SEC on December 31, 2019)
Lease to 3545 Cray Court, dated August 22, 2019 (Filed With SEC on November 4, 2019)
Amended and Restated Fourth Amendment to Lease to 9393 Towne Centre Drive, dated August 22, 2019 (Filed With SEC on November 4, 2019)
Amended and Restated 2013 Equity Incentive Plan, as amended, and Form of Stock Option Agreement and Form of Stock Option Grant Notice thereunder (Filed With SEC on August 5, 2019)
Underwriting Agreement, dated June 24, 2019 (Filed With SEC on June 25, 2019)
Clinical Trial Collaboration and Supply Agreement, dated January 3, 2019, by and between Mirati Therapeutics, Inc. and Bristol-Myers Squibb Company, and related Supply/Quality... (Filed With SEC on April 29, 2019)
Drug Discovery Collaboration Option Agreement, dated October 1, 2014, by and between Mirati Therapeutics, Inc. and Array BioPharma Inc., and related amendments dated August 13,... (Filed With SEC on April 29, 2019)
Amended and Restated 2013 Equity Incentive Plan and Form of Stock Option Grant Notice and Form of Stock Option Agreement thereunder (Filed With SEC on February 28, 2019)
Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 28, 2019)
Underwriting Agreement, dated January 16, 2019 (Filed With SEC on January 17, 2019)